Patents-Review.com
ClassID:

170692 ⎘

G01N2400/02 - CPC Classification

Classification description:

Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins

Recent Application in this class:
#1
20260153509
2026-06-04

BORRELIA BURGDORFERI PEPTIDOGLYCAN AS A DIAGNOSTIC AND TARGET FOR THERAPEUTIC INTERVENTION OF LYME DISEASE-RELATED PATHOLOGIES

 #2
20250298019
2025-09-25

BORRELIA BURGDORFERI PEPTIDOGLYCAN DETECTION METHODS

 #3
20250298012
2025-09-25

METHODS AND KITS FOR QUANTIFYING GLYCOSYLATED ANALYTES

 #4
20250138009
2025-05-01

OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS

 #5
20240343834
2024-10-17

Compositions and Methods for Targeting Cancer Stem Cells

 #6
20240307535
2024-09-19

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

 #7
20240270869
2024-08-15

ANTIBODY OR FRAGMENT THEREOF, AND METHOD FOR USING SAME

 #8
20240239873
2024-07-18

NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE

 #9
20240182603
2024-06-06

SULFUR-SUBSTITUTED SUGAR TO STABILIZE OLIGOSACCHARIDE

 #10
20240077486
2024-03-07

Flow Cytometry Platform for the Detection of Glycosylated Proteins in a Clinical Sample

 #11
20230287521
2023-09-14

BRASSICA GAT EVENT AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF

 #12
20230174664
2023-06-08

ANTIBODIES TO CARBOHYDRATE ANTIGENS

 #13
20230138529
2023-05-04

Methods of treating gastrointestinal diseases characterized by inflammatory cells

 #14
20230003726
2023-01-05

A METHOD OF ISOLATING EXOSOMES

 #15
20220357337
2022-11-10

ASSESSMENT OF DISEASE RISK FACTORS IN CORRELATION WITH NEU5GC INGESTED IN FOOD

 #16
20220236275
2022-07-28

CANCER TEST METHOD

 #17
20220227820
2022-07-21

RECOMBINANT GLYCAN BINDING PROTEINS

 #18
20220185838
2022-06-16

CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN

 #19
20220184196
2022-06-16

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES

 #20
20220168420
2022-06-02

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

 #21
20210389312
2021-12-16

Method for detecting target substance, reagent for detecting target substance

 #22
20210364515
2021-11-25

OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS

 #23
20210364514
2021-11-25

BORRELIA BURGDORFERI PEPTIDOGLYCAN AS A DIAGNOSTIC AND TARGET FOR THERAPEUTIC INTERVENTION OF LYME DISEASE-RELATED PATHOLOGIES

 #24
20210311043
2021-10-07

METHOD FOR DETERMINING A LECTIN-BINDING GLYCAN INDICATIVE TO TRAUMATIC BRAIN INJURY

 #25
20210284719
2021-09-16

Human antibodies, pharmaceutical compositions and methods

 #26
20210132082
2021-05-06

Kit for tracking and diagnosing degree of progressive chronic hepatitis and liver fibrosis by measuring asialo (alpha)1-acid glycoprotein as hepatocellular injury marker and use thereof

 #27
20210088507
2021-03-25

Stimuli-responsive surfaces

 #28
20210079067
2021-03-18

Neutralizing antibodies to ebola virus glycoprotein and their use

 #29
20210061838
2021-03-04

Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein

 #30
20210048437
2021-02-18

MEANS AND METHODS FOR GLYCOPROFILING OF A PROTEIN

 #31
20200371115
2020-11-26

APOE MODIFICATIONS AND USES THEREOF

 #32
20200319189
2020-10-08

Diagnostic test for hepatocellular carcinoma

 #33
20200316199
2020-10-08

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

 #34
20200264186
2020-08-20

BIOMARKERS TO DETECT AND CHARACTERISE CANCER

 #35
20200239591
2020-07-30

Saccharide-based biomarkers and therapeutics

 #36
20200225224
2020-07-16

Optimizing diagnostics for galactofuranose containing antigens

 #37
20200109435
2020-04-09

DNA-glycan conjugates and methods of use

 #38
20200061176
2020-02-27

Methods and compositions for treating and diagnosing autoimmune diseases

 #39
20200057078
2020-02-20

MELANOTRANSFERRIN FOR USE IN THE DIAGNOSIS OF PARKINSON`S DISEASE

 #40
20200003772
2020-01-02

NON-INVASIVE BRAIN INJURY DIAGNOSTIC DEVICE

 #41
20190388447
2019-12-26

Glycan-based drugs, therapies and biomarkers

 #42
20190383820
2019-12-19

DETECTING CANCER STEM CELLS USING A GLYCAN BIOMARKER

 #43
20190343960
2019-11-14

Glycoconjugates and methods for their use

 #44
20190309095
2019-10-10

Synthetic oligosaccharide subunits of the Psl exopolysaccharide of pseudomonas aeruginosa and uses thereof

 #45
20190211077
2019-07-11

Fc-binding protein, method for producing said protein, antibody adsorbent using said protein, and method for separating antibody using said adsorbent

 #46
20190106507
2019-04-11

Antibody-drug conjugates containing anti-Globo H antibodies and uses thereof

 #47
20190056386
2019-02-21

ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION

 #48
20190038747
2019-02-07

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

 #49
20180327438
2018-11-15

Carbohydrate ligands that bind to IGM antibodies against myelin-associated glycoprotein

 #50
20180265910
2018-09-20

Cleavage of Fucose in N-Glycans

 #51
20180203000
2018-07-19

Method for detecting protein-specific glycosylation

 #52
20180156797
2018-06-07

Optimizing diagnostics for galactofuranose containing antigens

 #53
20180149658
2018-05-31

METHODS AND KITS FOR CANCER ANTIGEN AND HEPARAN SULFATE IMAGING

 #54
20180143186
2018-05-24

KIT-OF-PARTS TO IDENTIFY MOTHER'S MILK MISSING FUCOSYLTRANSFERASE-2 DEPENDENT GLYCANS AND FEEDING DOSES WITH SAID GLYCANS

 #55
20180134799
2018-05-17

Antibodies, pharmaceutical compositions and uses thereof

 #56
20180110889
2018-04-26

Method for detecting AFP

 #57
20180106814
2018-04-19

METHOD FOR MEASURING GLYCOPROTEIN, METHOD FOR EXAMINING LIVER DISEASE, REAGENT FOR QUANTITATIVE DETERMINATION OF GLYCOPROTEIN, AND GLYCAN-MARKER GLYCOPROTEIN AS AN INDEX FOR CLINICAL CONDITIONS OF LIVER DISEASE

 #58
20180095090
2018-04-05

Biomarkers for assessment of preeclampsia

 #59
20170342140
2017-11-30

Monoclonal antibody reacting with glycopeptide, and use thereof

 #60
20170333568
2017-11-23

Glycoconjugates and methods for their use

 #61
20170267777
2017-09-21

Saccharide-based biomarkers and therapeutics

 #62
20170198056
2017-07-13

Anti-MUC1 antibody or antigen-binding fragment thereof and uses thereof

 #63
20170196962
2017-07-13

Streptococcal GlcNac-lacking gylcopolypeptides, cell wall carbohydrates, vaccines, and methods for making and using them

 #64
20170138932
2017-05-18

Assays for B-type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation

 #65
20170122940
2017-05-04

Sandwich assay using labeled lectin and kit therefor

 #66
20170108510
2017-04-20

A-fucosylation detection in antibodies

 #67
20170108505
2017-04-20

Methods and reagents for the assessment of gestational diabetes

 #68
20170067885
2017-03-09

Glycan arrays and method of use

 #69
20170056489
2017-03-02

Oligosialic acid derivatives, methods of manufacture, and immunological uses

 #70
20170052185
2017-02-23

BIOMARKERS FOR PROSTATE CANCER AND METHODS FOR THEIR DETECTION

 #71
20170029526
2017-02-02

Antibodies, pharmaceutical compositions and uses thereof

 #72
20170022239
2017-01-26

Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein

 #73
20170008977
2017-01-12

GLYCOPEPTIDE AND USES THEREOF

 #74
20160311922
2016-10-27

GLYCAN-INTERACTING COMPOUNDS

 #75
20160137743
2016-05-19

Glycan-interacting compounds

 #76
20160068884
2016-03-10

METHODS FOR DETERMINING PRESENCE OR ABSENCE OF GLYCAN EPITOPES ON GLYCOPROTEINS

 #77
20160053292
2016-02-25

Galactose-alpha-1, 3-galactose-containing n-glycans in glycoprotein products derived from CHO cells

 #78
20160032010
2016-02-04

Method for preparing glycan-hydrolyzed antibody, and homogeneous glycosylated antibody

 #79
20160015729
2016-01-21

Glycan-based drugs, therapies and biomarkers

 #80
20160003839
2016-01-07

Detection of free and protein-bound non-human gal-alpha(1-3)-gal epitope

 #81
20160003828
2016-01-07

BREAST-CANCER DETERMINATION METHOD

 #82
20150355176
2015-12-10

Immunoassay method less affected by impurities

 #83
20150260720
2015-09-17

Method and kit for distinguishing between prostate carcinoma and benign prostatic hyperplasia

 #84
20150241450
2015-08-27

Methods of detecting conjugation site-specific and hidden epitope/antigen

 #85
20150192581
2015-07-09

Lateral flow device for diagnosing microbial infections

 #86
20150087806
2015-03-26

Glycopeptide and uses thereof

 #87
20150024410
2015-01-22

Method for determining the glycosylation of an antibody

 #88
20140323699
2014-10-30

Method of detecting cancer based on glycan biomarkers

 #89
20140322825
2014-10-30

Lambodies with high affinity and selectivity for glycans and uses therefor

 #90
20140308238
2014-10-16

Immunomodulating compositions and methods of use thereof

 #91
20140296167
2014-10-02

Glycosylation site-specific antibodies and anti-cancer compounds

 #92
20140212473
2014-07-31

Glycopeptide and uses thereof

 #93
20140199242
2014-07-17

Compositions and methods for detection and treatment of cancer

 #94
20130323282
2013-12-05

Compositions and methods

 #95
20130156813
2013-06-20

Biomarkers for prostate cancer and methods for their detection

 #96
20130017561
2013-01-17

Lateral flow device for diagnosing microbial infections

 #97
20120282628
2012-11-08

Method for diagnosing cancer using lectin

 #98
20120244632
2012-09-27

Sterol glucoside toxins

 #99
20120219975
2012-08-30

Galactose-alpha-1,3-galactose-macromolecule conjugates and methods employing same

 #100
20120207737
2012-08-16

MEDICAL UTILITY OF GLYCAN-BINDING PROTEINS AND GLYCANS

 #101
20120196310
2012-08-02

A-FUCOSYLATION DETECTION IN ANTIBODIES

 #102
20120190576
2012-07-26

Glycan markers as measure of disease state of hepatic diseases

 #103
20120177636
2012-07-12

CARBOHYDRATE-CONTAINING PAN CANCER MARKER

 #104
20120172247
2012-07-05

Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease

 #105
20120165221
2012-06-28

DIAGNOSIS OF CANCERS THROUGH GLYCOME ANALYSIS

 #106
20120141431
2012-06-07

METHODS FOR IDENTIFYING, ISOLATING, AND UTILIZING ENDOCRINE PROGENITOR CELLS FROM ADULT HUMAN PANCREAS

 #107
20120077758
2012-03-29

INFERTILITY ASSOCIATED DEFB-126 DELETION POLYMORPHISM

 #108
20120039984
2012-02-16

GLYCOPEPTIDE AND USES THEREOF

 #109
20120003754
2012-01-05

Methods, products and treatments for diabetes

 #110
20110318765
2011-12-29

Method for pre-treating sample containing glycated hemoglobin

 #111
20110287559
2011-11-24

Method of characterizing glycans attached to glycoproteins

 #112
20110201023
2011-08-18

MANNOSE 6-PHOSPHATE-BINDING ANTIBODIES AND THEIR USES

 #113
20110177532
2011-07-21

Immunomodulating compositions and methods of use thereof

 #114
20110124013
2011-05-26

Galactose-α-1,3-galactose-macromolecule conjugates and methods employing same

 #115
20110085981
2011-04-14

Glycan-based drugs, therapies and biomarkers

 #116
20110045496
2011-02-24

Gal α1-3gal-containing N-glycans in glycoprotein products derived from CHO cells

 #117
20110033875
2011-02-10

Glycoprotein cancer biomarker

 #118
20110033445
2011-02-10

Carbohydrate-containing pan cancer marker

 #119
20110021376
2011-01-27

Method for analyzing a glycomolecule

 #120
20100330594
2010-12-30

Early detection of diabetes

 #121
20100254898
2010-10-07

Antibodies that bind GalNAc1-3Gal, pharmaceutical compositions and methods of using same

 #122
20100216163
2010-08-26

Lectin-based glycan assay

 #123
20100173324
2010-07-08

Anti-CD27 antibody

 #124
20100129934
2010-05-27

Glycated Insulin as a Biomarker for Diagnosis and Monitoring of Diabetes

 #125
20100120058
2010-05-13

IgE antibodies to chimeric or humanized IgG therapeutic monoclonal antibodies as a screening test for anaphylaxis

 #126
20100105085
2010-04-29

METHOD OF DIAGNOSING AND STRATIFYING ANTI-PHOSPHOLIPID SYNDROME

 #127
20100075344
2010-03-25

Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes

 #128
20100062416
2010-03-11

Immobilisation and application of antigenic carbohydrates to detect infective micro-organisms

 #129
20100015632
2010-01-21

METHOD FOR EXAMINING COLORECTAL CANCER AND COLORECTAL ADENOMA

 #130
20090281022
2009-11-12

Method for Producing Factor VII Glycoforms

 #131
20090275512
2009-11-05

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION

 #132
20090191574
2009-07-30

Methods, products and treatments for diabetes

 #133
20090148865
2009-06-11

Polysaccharide structure and sequence determination

 #134
20090023637
2009-01-22

Methods for detecting and treating interstitial cystitis

 #135
20090010944
2009-01-08

Oligosialic acid derivatives, methods of manufacture, and immunological uses

 #136
20090004750
2009-01-01

Method of Diagnosing Cerebral Infarction

 #137
20080268477
2008-10-30

Antibody Reactive Specifically to Age Derived from 3,4-Dge

 #138
20080233087
2008-09-25

Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata

 #139
20080200348
2008-08-21

Polysaccharide structure and sequence determination

 #140
20080171399
2008-07-17

Forensic Test for Human Blood

 #141
20080096234
2008-04-24

Method for examining carcinoma and adenoma

 #142
20080085838
2008-04-10

Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof

 #143
20080045444
2008-02-21

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION

 #144
20080014570
2008-01-17

Method Of Removing Adhesive Microvesicles

 #145
20070287679
2007-12-13

Ornithine aminotransferase (OAT): a target for anticancer drugs

 #146
20070275483
2007-11-29

Biomarker isolation and use thereof to characterize physiological state

 #147
20070213297
2007-09-13

Arrays with cleavable linkers

 #148
20070213278
2007-09-13

Arrays with cleavable linkers

 #149
20070196874
2007-08-23

Method of examining colon cancer and colon adenoma

 #150
20070155801
2007-07-05

Advanced glycation end-product intermediaries and post-amadori inhibition

 #151
20070122884
2007-05-31

Factor VII glycoforms

 #152
20060270060
2006-11-30

Rapid test for glycated albumin in saliva

 #153
20060257936
2006-11-16

Methods, products and treatments for diabetes

 #154
20060252705
2006-11-09

Sterol glucoside toxins

 #155
20060246496
2006-11-02

Method and assay for early diagnosis of prostate cancer

 #156
20060240496
2006-10-26

Immunogens, derivatives and immunoassay for ethyl glucuronide

 #157
20060228762
2006-10-12

Diagnosis of human glycosylation disorders

 #158
20060211042
2006-09-21

Methods of identifying modulators of cellular glycosylation using GTRAP3-18

 #159
20060194269
2006-08-31

Polysaccharide structure and sequence determination

 #160
20060177876
2006-08-10

Method for diagnosing liver diseases

 #161
20060166293
2006-07-27

Zinc alpha-2-glycoprotein as indicator of cancer

 #162
20060165728
2006-07-27

Campylobacter glycans and glycopeptides

 #163
20060121532
2006-06-08

Glycated insulin as a biomarker for diagnosis and monitoring of diabetes

 #164
20060057634
2006-03-16

Assay for glycosylated proteins

 #165
20060019344
2006-01-26

C-erbB-2 external domain: gp75

 #166
20050277154
2005-12-15

Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof

 #167
20050186645
2005-08-25

Method for analyzing a glycomolecule

 #168
20050148024
2005-07-07

Methods and compositions for measuring natriuretic peptides and uses thereof

 #169
20050112691
2005-05-26

Marker for measuring liver cirrhosis

 #170
20050075289
2005-04-07

Factor VII glycoforms

 #171
20050037434
2005-02-17

Monoclonal antibody against costimulatory molecule M150 and a process for preparation thereof